Closed · RFA-HD-21-026 · CFDA 93.865 · Discretionary
Maternal and Pediatrics Precision in Therapeutics Hub (MPRINT) (P50 Clinical Trial Optional)
Federal grant opportunity posted by National Institutes of Health, cataloged on Grants.gov.
- up to $850K
- Award range
- Closed
- Status
- November 30, 2020
- Close date
- 2
- Expected awards
The verdict
Maternal and Pediatrics Precision in Therapeutics Hub (MPRINT) (P50 Clinical Trial Optional) is a closed discretionary listing from National Institutes of Health that offered Up to $850,000 across 2 expected awards. Future funding cycles may be published under the same CFDA number.
- up to $850K
- award range
- Closed
- application status
- 2
- expected awards
- 93.865
- CFDA program
Opportunity snapshot. This Grants.gov announcement - Maternal and Pediatrics Precision in Therapeutics Hub (MPRINT) (P50 Clinical Trial Optional) - is cataloged under number RFA-HD-21-026 and tied to CFDA assistance listing 93.865, posted by National Institutes of Health. Grants.gov currently shows the opportunity as closed, first posted on August 3, 2020. The funding category is Discretionary, delivered as a grant.
Award economics. The award range on file is Up to $850,000. The agency has projected $2.5 million in total estimated funding for this announcement. It expects to issue 2 awards. If the agency funds the expected 2 awards from the $2.5 million estimated pool, the average award works out to roughly $1.3 million. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.
Deadline and action path. This opportunity closed on November 30, 2020. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.
Award Range
Up to $850,000
Close Date
November 30, 2020
Posted
August 3, 2020
Est. Total Funding
$2,500,000
Expected Awards
2
Instrument
Grant
Description
This Funding Opportunity Announcement (FOA) invites applications to form Centers of Excellence in Therapeutics (CETs) as part of the NICHDs Maternal and Pediatric Precision in Therapeutics (MPRINT) Hub. The MPRINT Hub will serve as a national resource for expertise in maternal and pediatric therapeutics to conduct and foster therapeutics-focused research in obstetrics, lactation, and pediatrics while enhancing inclusion of people with disabilities. By serving as a national resource, it will aggregate, present, and expand the available knowledge, tools, and expertise in maternal and pediatric therapeutics to the broader research, regulatory science, and drug development communities. The MPRINT CETs will work together and with the MPRINT Knowledge and Research Coordination Center (KRCC; RFA-HD-21-025), the central coordinating center of the MPRINT Hub, to serve as a national resource for knowledge and expertise in maternal and pediatric pharmacology and as a research center to close deficits in knowledge and technical expertise. The MPRINT CETs will conduct cutting edge clinical, translational, basic, and/or data sciences research, provide resources, and generate novel tools and approaches to advance and accelerate research and regulatory science in maternal and pediatric therapeutics. The MPRINT KRCC will serve as the primary public-facing component of the MPRINT Hub and as a conduit to the resources of the MPRINT CETs.
Eligibility
Grants.gov lists this opportunity under eligibility category codes 00, 01, 02, 04, 05, 06, 07, 08, 11, 12, 13, 20, 22, 23, 25. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
NIH OER Webmaster FBOWebmaster@OD.NIH.GOV
Key Dates
Frequently Asked Questions
What is this grant opportunity?
Is this opportunity still open?
How much funding is available?
How do I apply?
More from National Institutes of Health
Validation Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U54 Clinical Trials Not Allowed)
Logistics Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U24 Clinical Trials Not Allowed)
Development and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U01 Clinical Trial Not Allowed)
PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (UG3/UH3 Clinical Trial Optional)
Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (UG3/UH3, Clinical Trial Optional)
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
Related
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |